{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:15:46Z","timestamp":1781478946691,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jocn.2025.111328","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T03:13:31Z","timestamp":1747365211000},"page":"111328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Disproportionality analysis of progestogens and estrogens demonstrates increased meningioma risk"],"prefix":"10.1016","volume":"137","author":[{"given":"Connor","family":"Frey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahyar","family":"Etminan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2025.111328_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.579599","article-title":"Meningioma: A Review of Clinicopathological and Molecular Aspects","volume":"10","author":"Huntoon","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jocn.2025.111328_b0010","article-title":"Meningioma: Molecular Updates from the 2021 WHO Classification of CNS Tumors and Imaging Correlates","author":"Soni","year":"2024","journal-title":"Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.jocn.2025.111328_b0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clineuro.2009.12.011","article-title":"Management of meningiomas","volume":"112","author":"Alexiou","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jocn.2025.111328_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.611218","article-title":"Progesterone Receptor Expression in Meningiomas: Pathological and Prognostic Implications","volume":"11","author":"Maiuri","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jocn.2025.111328_b0025","series-title":"Oral Contraceptive Pills","author":"Cooper","year":"2024"},{"key":"10.1016\/j.jocn.2025.111328_b0030","series-title":"Hormone Replacement Therapy","author":"Harper-Harrison","year":"2024"},{"issue":"3","key":"10.1016\/j.jocn.2025.111328_b0035","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/cancers15030980","article-title":"Hormone Receptor Expression in Meningiomas: A Systematic Review","volume":"15","author":"Agopiantz","year":"2023","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.jocn.2025.111328_b0040","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/ene.15423","article-title":"Risk of intracranial meningioma with three potent progestogens: A population-based case\u2013control study","volume":"29","author":"Hoisnard","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2025.111328_b0045","article-title":"Use of progestogens and the risk of intracranial meningioma: National case-control study","volume":"384","author":"Roland","year":"2024","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jocn.2025.111328_b0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1515\/med-2017-0029","article-title":"Pathophysiology of meningioma growth in pregnancy","volume":"12","author":"Hortob\u00e1gyi","year":"2017","journal-title":"Open Medicine"},{"issue":"6","key":"10.1016\/j.jocn.2025.111328_b0055","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3171\/2023.3.JNS221838","article-title":"A systematic review and individual participant data meta-analysis of gonadal steroid hormone receptors in meningioma","volume":"139","author":"Miyagishima","year":"2023","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2025.111328_b0060","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1038\/s41598-020-74344-x","article-title":"Estrogen hormone replacement therapy in incidental intracranial meningioma: A growth-rate analysis","volume":"10","author":"Dresser","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jocn.2025.111328_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157753","article-title":"OpenVigil FDA \u2013 Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications","volume":"11","author":"B\u00f6hm","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jocn.2025.111328_b0070","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data Mining of the Public Version of the FDA Adverse Event Reporting System","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int J Med Sci"},{"issue":"5","key":"10.1016\/j.jocn.2025.111328_b0075","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40264-020-00911-w","article-title":"Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations","volume":"43","author":"Caster","year":"2020","journal-title":"Drug Saf"},{"key":"10.1016\/j.jocn.2025.111328_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fdsfr.2023.1323057","article-title":"Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems","volume":"3","author":"Cutroneo","year":"2024","journal-title":"Front Drug Saf Regul"},{"key":"10.1016\/j.jocn.2025.111328_b0085","unstructured":"OpenVigil. (2024). OpenVigil. https:\/\/openvigil.sourceforge.net\/."},{"issue":"19","key":"10.1016\/j.jocn.2025.111328_b0090","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.3390\/cancers16193362","article-title":"The Association between Medroxyprogesterone Acetate Exposure and Meningioma","volume":"16","author":"Griffin","year":"2024","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.jocn.2025.111328_b0095","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00701-021-04781-8","article-title":"Sustained growth of intraosseous hormone-associated meningiomas after cessation of progestin therapy","volume":"163","author":"AbiJaoude","year":"2021","journal-title":"Acta Neurochir"},{"issue":"6","key":"10.1016\/j.jocn.2025.111328_b0100","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neuchi.2021.04.018","article-title":"Meningiomas in patients with long-term exposition to progestins: Characteristics and outcome","volume":"67","author":"Graillon","year":"2021","journal-title":"Neurochirurgie"},{"issue":"1\u20136","key":"10.1016\/j.jocn.2025.111328_b0105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0022-4731(89)90119-2","article-title":"Effect of steroids and antisteroids on human meningioma cells in primary culture","volume":"34","author":"Blankenstein","year":"1989","journal-title":"J Steroid Biochem"},{"issue":"1","key":"10.1016\/j.jocn.2025.111328_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-006-9146-9","article-title":"Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression","volume":"80","author":"Korhonen","year":"2006","journal-title":"J Neurooncol"},{"issue":"7","key":"10.1016\/j.jocn.2025.111328_b0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/aje\/kwj254","article-title":"Risk of Brain Tumors Associated with Exposure to Exogenous Female Sex Hormones","volume":"164","author":"Wigertz, A., L\u00f6nn, S., Mathiesen, T., Ahlbom, A., Hall, P., Feychting, M., & and the Swedish INTERPHONE Study Group","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.jocn.2025.111328_b0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1227\/00006123-199507000-00014","article-title":"Progesterone and glucocorticoid receptor activation in meningiomas","volume":"37","author":"Carroll","year":"1995","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.jocn.2025.111328_b0125","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3171\/2009.8.JNS09201","article-title":"Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy","volume":"112","author":"Vadivelu","year":"2010","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.jocn.2025.111328_b0130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/annonc\/mdx763","article-title":"Progestin-associated shift of meningioma mutational landscape","volume":"29","author":"Peyre","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jocn.2025.111328_b0135","article-title":"Use of high dose cyproterone acetate and risk of intracranial meningioma in women: Cohort study","volume":"372","author":"Weill","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jocn.2025.111328_b0140","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3171\/2022.12.JNS222006","article-title":"Opposed evolution of the osseous and soft parts of progestin-associated osteomeningioma after progestin intake discontinuation","volume":"139","author":"Florea","year":"2023","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2025.111328_b0145","doi-asserted-by":"crossref","first-page":"814.e7","DOI":"10.1016\/j.wneu.2017.03.013","article-title":"Dramatic Shrinkage with Reduced Vascularization of Large Meningiomas After Cessation of Progestin Treatment","volume":"101","author":"Kalamarides","year":"2017","journal-title":"World Neurosurg"},{"issue":"4","key":"10.1016\/j.jocn.2025.111328_b0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3171\/jns.1979.50.4.0499","article-title":"Estrogen-receptor protein in intracranial meningiomas","volume":"50","author":"Donnell","year":"1979","journal-title":"J Neurosurg"},{"issue":"10","key":"10.1016\/j.jocn.2025.111328_b0155","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/and.12550","article-title":"Meningiomas in three male-to-female transgender subjects using oestrogens\/progestogens and review of the literature","volume":"48","author":"Ter Wengel","year":"2016","journal-title":"Andrologia"},{"issue":"1","key":"10.1016\/j.jocn.2025.111328_b0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00701-021-05005-9","article-title":"Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: Clinical cases and histomolecular characterization","volume":"164","author":"Passeri","year":"2022","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.jocn.2025.111328_b0165","article-title":"Prolonged use of nomegestrol acetate and risk of intracranial meningioma: A population-based cohort study. The Lancet Regional Health \u2013","volume":"42","author":"Nguyen","year":"2024","journal-title":"Europe"},{"issue":"12","key":"10.1016\/j.jocn.2025.111328_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083261","article-title":"Reproductive and Exogenous Hormone Factors in Relation to Risk of Meningioma in Women: A Meta-Analysis","volume":"8","author":"Qi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jocn.2025.111328_b0175","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/j.wneu.2020.11.175","article-title":"Relationship Between Oral Contraceptives and the Risk of Gliomas and Meningiomas: A Dose-Response Meta-Analysis and Systematic Review","volume":"147","author":"Yang","year":"2021","journal-title":"World Neurosurg"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825003005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825003005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T11:29:46Z","timestamp":1750332586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586825003005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":35,"alternative-id":["S0967586825003005"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111328","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disproportionality analysis of progestogens and estrogens demonstrates increased meningioma risk","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111328"}}